JCDD, Vol. 12, Pages 472: Percutaneous Treatment of Mitral Regurgitation After Failed Mitral Transcatheter Edge-to-Edge Repair


JCDD, Vol. 12, Pages 472: Percutaneous Treatment of Mitral Regurgitation After Failed Mitral Transcatheter Edge-to-Edge Repair

Journal of Cardiovascular Development and Disease doi: 10.3390/jcdd12120472

Authors:
André González-García
Julio Echarte-Morales
Manuel Barreiro-Pérez
José Antonio Baz-Alonso
Andrés Íñiguez-Romo
Rodrigo Estévez-Loureiro

Mitral regurgitation is one of the most prevalent valvular heart diseases globally and the second most common indication for cardiac valve surgery, surpassed only by aortic stenosis. Over the past decades, open-heart mitral valve surgery has been the gold-standard intervention for this complex disorder, but in recent years, transcatheter edge-to-edge repair has emerged as a valuable option in selected clinical scenarios. However, a considerable proportion of patients develop recurrent mitral regurgitation during follow-up, leading to a significant increase in morbidity and mortality. In this context, data is limited regarding the optimal approach. This review provides an overview of the current evidence on transcatheter mitral valve intervention therapies for the management of recurrent mitral regurgitation following transcatheter edge-to-edge repair.



Source link

André González-García www.mdpi.com